GlycoMimetics Stock (NASDAQ: GLYC) stock price, news, charts, stock research, profile.
Open | $0.23 |
Close | $0.24 |
Volume / Avg. | 1.46M / 4.52M |
Day Range | 0.23 - 0.25 |
52 Wk Range | 0.20 - 3.53 |
Market Cap | $15.55M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 37 |
Short Interest | 6.38% |
Days to Cover | 2.41 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of GlycoMimetics (NASDAQ:GLYC) through any online brokerage.
Other companies in GlycoMimetics’s space includes: Vincerx Pharma (NASDAQ:VINC), Galecto (NASDAQ:GLTO), Immuron (NASDAQ:IMRN), Imunon (NASDAQ:IMNN) and Monopar Therapeutics (NASDAQ:MNPR).
There is no analysis for GlycoMimetics.
GlycoMimetics has a consensus price target of $8.00.
The stock price for GlycoMimetics (NASDAQ: GLYC) is $0.2412 last updated July 26, 2024 at 7:59 PM EDT.
There are no upcoming dividends for GlycoMimetics.
GlycoMimetics’s Q2 earnings are confirmed for Friday, August 9, 2024.
There is no upcoming split for GlycoMimetics.
GlycoMimetics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.